Outcome measures in treatment trials in bipolar disorder

Bipolar Disorders

Volumn 4, Issue SUPPL. 1, 2002, Pages 64-65

  Nolen, W A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Bipolar disorder; Life chart method; Outcome measures

Indexed keywords

LAMOTRIGINE; PLACEBO;

ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; HUMAN; MAINTENANCE THERAPY; MANIA; MANIC DEPRESSIVE PSYCHOSIS; MOOD; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOSOMATIC DISORDER; RATING SCALE; SCORING SYSTEM; SENSITIVITY ANALYSIS; SYMPTOMATOLOGY; VALIDATION PROCESS;

ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; CONTROLLED CLINICAL TRIALS; HUMANS; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME; TRIAZINES;

EID: 0036383620     PISSN: 13985647     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-5618.4.s1.26.x     Document Type: Article

References (4)

1. Calabrese JR, Bowden CL, Sachs GS et al. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 1999; 60: 79-88.
2. Leverich GS, Post RM. Life charting of affective disorders. CNS Spectrums 1998; 3: 21-37.
3. Denicoff KD, Smith-Jackson EE, Disney ER, Suddath RL, Leverich GS, Post RM. Preliminary evidence of the reliability and validity of the prospective life-chart methodology (LCM-p). J Psychiatr Res 1997; 31: 593-603.
4. Calabrese JR, Suppes T, Bowden CL et al. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry 2000; 61: 841-850.